HIV Flashcards
preferred INSTIs for use in pregnancy
RAL or DTG
K65R
tenofovir
Q148R and N155H
integrase inhibitor
Time window for PEP
72 hours
G140S and Q148R
Dolutegravir
Methods to acquire toxoplasmosis
feline feces (cats have to be outdoor eating rodents)
eating rare meat (lamb, beef, pork)
congenital transmission
Definitive diagnosis of CNS too
brain biopsy
CSF PCR
Serum PCR
Preferred therapy for CNS toxo
sulfadiazine, pyrimethamine, leucovorin
TMP-SMX
alternative therapies for CNS toxo
clindamycin plus pyrimethamine
atovaquone plus pyrimethamine
Toxo PPX IgG + and CD4 <100
TMP-SMX
Dapsone-pyrimethamine
Atovaquone pyrimethamine
m haemophilum culture
32C with iron enriched medium
positive PPD for HIV
5 mm
When to start ART after TB treatment started CD4 < 50
2 weeks
when to start ART after TB treatment started CD4 > 50
8 weeks
requirement for TB drug therapy in HIV
must be daily dosed drugs
when to start ART after Mac therapy
within 2 weeks
treatment for dMAC
clarithromycin/azithromycin plus EMB
rifabutin is optional third drug for severe disease
issue with CSF Crypto PCR
can have false negatives, always use CrAg
CSF PCR crypto utility
distinguish between IRIS (PCR negative) and relapse (PCR positive)T
treatment Course of Crypto meningitis
2 weeks induction (LAMB 5-FC)
8 weeks consolidation (Fluc 800 qd)
Maintenance Fluc 200 qd (52 weeks)
when to stop therapy for cryptococcal meningitis
stop after 12 months therapy if
CD4 is greater than 100-150 for more than 3 months
Asymptomatic
VL < 50 copies
utility of monitoring CSF Crag while on therapy
none
when to monitor 5-FC levels
after dose 3 or 5
when to start ART after cryptococcal meningitis
4-6 weeks
when to screen patients for crypto
if CD4 <100
management of positive CrAg
LP and blood cultures
If CSF positive or serum LFA > 640 treat like meningitis
If CSF negative treat with fluconazole 400 mg or 800 mg x 6 months
flucytosine toxicity
marrow suppression
hepatitis
diarrhea
talaromyces treatment
amp or itraconazole
talaromyces seen in
asia
HIV–2 is naturally resistant to which drug classes
NNRTIs
fusion inhibitors
HIV-2 is commonly seen in
west africa
france
spain
india
flower cells
typical of HTLV-1
HTLV-1 commonly seen in
caribbean
australia
HTLV-2 clinical significance
none does not cause disease in humans
T/F HTLV-1 can be transmitted by breastfeeding
true
HTLV-1 CANCER association
Acute T cell leukemia
HTLV-1 infectious syndromes
TB
MAC
Leprosy
PCP
recurrent strongyloides
scabes/norwegian scabies
Associated neuro syndrome with HTLV-1
tropical spastic paraparesis
features of tropical spastic paraparesis
bladder disturbance
hyperreflexia
positive babinski
role of ART in HTLV-1
none
clinical features of CJD
myoclonus and dementia
most common CJD transmission route
spontaneous
which CSF marker is most consistent with CJD
RT-QuIC test
what is the second best marker for CJD
elevated 14-3-3 proteins in CSF
EEG in CJD
periodic sharp waves
EEG findings in variant CJD
none
MRI findings in spontaneous CJD
double hockey stick sign
MR findings in variant CJD
pulvinar sign
bilateral FLAIR hyper intensities seen in the thalamic nuclei
pathology in sCJD
abnormal prion accumulation
pathology in vCJD
florid plaques
dura mater graft association acquiring iatrogenic CJD seen in what country
Japan
ingestion of beef causing CJD seen in which two countries most frequently
UK and France
oral hairy leukoplakia associated with
EBV
When to start ART with TB CD4 <50 or pregnant
within 2 weeks of diagnosis
when to start ART with TB CD4 > 50
within 8 weeks of diagnosis
when to start ART with cryptococcal meningitis
4-6 weeks after initiation of treatment for crypto
when to start ART after PML or cryptosporidiosis
immediately
what vaccines are CI with CD4 <200
MMR, Varicella, oral typhoid, yellow fever
side effect of pentamidine
hypoglycemia
what drugs should only be given after screening for G6PD
primaquine
dapsone
methmeglobinemia associated drugs
dapsone
primaquine
pentamidine cardiac side effect
torsades de pointe
rapid hiv test positive during woman in labor next step
start therapy while waiting for confirmatory testing
HIV non Progressor testing
ELISA reactive
supplemental positive
HIV RNA may not be detectable
DTG/3TC can be used for initial therapy with what level of viral load
500,000 or less
rilpivirine should not be given with a viral load
> 100,000
exception to using DTG/3TC as initial therapy
HBV s Ag positive or no resistance results
options when you can’t use ABC, TAF or TDF
DTG/3TC
DRV/r + 3TC
DRV/r + RAL BID
side effects of Efavirenz
CNS toxicity (abnormal dreams)
rash
suicidality
Rilpivirine needs to be taken with
a meal
RPV is not well absorbed with
PPIs
atazanavir side effect
increased indirect bilirubin (Gilbert’s like syndrome) jaundice
BIC and DTG creatinine effect
inhibits absorption of creatinine so will see rise in creatinine
NNRTIs that are p450 inducers except
DOR
what class of drugs are p450 inhibitors
PIs
rifampin cannot be used with what class of drugs
PIs
SJS can be seen with what two ART drugs
nevirapine and etravirine
zidovudine side effects
anemia and neutropenia, fatigue
General side effect of NNRTIs
rash, can treat through unless they have constitutional symptoms
ABC side effects
cardiovascular
kidney stones
indinavir, atazanavir
hyperlipidemia seen with
PIs
peripheral neuropathy seen with what three ARTs
stavudine, zalcitabine, didanosine
TAF studied in PrEP only in
men
when is HIV RNA detectable after acquisition
10-11 days
when is HIV antibody detectable after acquisition
20-25 days
HIV screening in people on PrEP
HIV RNA before starting therapy and routine HIV RNA screening while on therapy
what is the recommended regimen to start in new HIV diagnosis but recently on cabotegravir for PrEP
Boosted DRV with TAF/TDF plus FTC or 3TC
don’t use INSTI unless you have genotype results without INSTI resistance
treatment of bacillary angiomatosis in HIV
Doxyxyline, Erythromycin, Azithromycin, Clarithromycin x 3 months
what method is the highest risk for HIV transmission from HIV positive source
blood transfusion
cabotegravir exclusions
no history of virologic failure, drug resistance or chronic HBV infection
M184V
FTC and 3TC
K65R
TDF
also ABC and DDI
K103N
Efavirenz
K65R mutation, which drug can be used to salvage
Zidovudine
If present K103N which NNRTI will still work
Doravirine
Y181C
Nevirapine
Rilpivirine failure is associated with
E183K, K101E and Y181C –> resistant to all NNRTIs
I50L
Atazanavir ATV
Elvitegravir resistance mutation
Q148R
Q148R resistance can be overcome by prescribing
BID dosing of DTG
which type of virus would indicate the highest likelihood of maraviroc activity
pure R5 virus
K103N retains susceptibility to
Etravirine
N155H
RAL and EVG
Y143C
RAL
R263K
DTG
when to start ART after OI (non CNS Crypto or TB)
2 weeks
can’t use rifampin with what class of ART
Protease inhibitors
RIF with DTG adjustment
double the dose of DTG 50 BID
which ART is effective against HBV
3TC, FTC and TDF/TAF
What HBV drug has activity against HIV
entecavir
regimen for HBV and HIV confection
2 active drugs against HBV and 3rd drug for HIV (preferred BIC and DTG)
what regimen is not recommended in pregnancy
two drug regimen
management of ART near delivery
if HIV RNA > 1000 or unknown use IV ZDV and C/section at 38 weeks
preferred regimen in pregnancy
2 NRTIs and 3rd drug (PI, INSTI or NNRTI)
NRTIs ok in pregnancy
ABC, 3TC, TDF/TAF, FTC
NNRTIs ok in pregnancy
EFV or RPV
which INSTI has insufficient data to use in pregnancy
BIC
INSTIs safe to use in pregnancy
DTG or RAL
Fanconi syndrome is what type of RTA
II
FAnconi syndrome affects what part of nephron
proximal tubule
electrolyte abnormalities in Fanconi
Hypophosphatemia
Renal Glucosuria
Hypouricemia
aminoaciduria
LOW proteinuria if any
complication of Fanconi syndrome
osteomalacia
dapsone risk
methmeglobinemia
HIVAN features
high grade proteinuria
NO EDEMA
rapid progression to ESRD
most effective method to prevent progression to ESRD in HIVAN
ART
treatment of HIV associated ITP
ART
effect of COBI and INSTI on Creatinine
decreases secretion of creatinine at the proximal tubule, see .1 to .2 increase in SCr
what class of drugs has no effect against HIV-2 infection
NNRTIs
what classes of drugs are effective against HIV-2
PIs, NRTIs, INSTIs
mycobacterium haemophilum requires what in media to grow
iron
leishmania media
NNN
marinum should be grown at
30C